ArticleOncotarget2022

Correction: Evaluation of 6-mercaptopurine in a cell culture model of adaptable triple-negative breast cancer with metastatic potential.

Balraj Singh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.